Japanese breweries are cutting the prices of their beer in hopes of regaining a foothold in South Korea after the ‘No Japan’ boycott campaign decimated its sales.
Lotte Mart is now selling four 500-milliliter cans of Asahi beer, imported and distributed by its affiliate Lotte Asahi Liquor Co., for 10,000 won.
The beer used to sell for more than 3,000 won per can before the boycott.
Asahi beer was the No. 1 in the imported beer market in South Korea.
This promotional event came after Lotte Asahi Liquor reduced its supply price.
Convenience store chains in South Korea such as 7-Eleven and CU are also selling Japanese beer at 2,500 won per can.
Other than Asahi beer, CU lowered the price of Asahi Group Holdings' Pilsner Urquell and Kozel brands to 2,500 won per can.
GS25 stores are also selling Asahi beer at 2,500 won.


TeamViewer Shares Fall Despite Profit Growth as ARR and Customer Base Decline
Rio Tinto Stock Jumps as Strong Earnings, Higher Dividend and AI Metal Demand Boost Outlook
Unilever Raises 2026 Sales Outlook After Strong Q2 Volume Growth
SK Hynix Q2 Profit Hits Record as AI Memory Chip Demand Fuels Growth
TSMC Gradually Restarts Japan Chip Plant After Kumamoto Earthquake
Zabka Shares Drop 10% as Seven & i Abandons Investment Plans
GSK Unveils $2.52 Billion Cost-Cutting Plan to Accelerate Drug Pipeline
Meta CEO Zuckerberg Opposes U.S. Ban on Chinese AI Models, Warns Against Overregulation
Brown-Forman Rejects Sazerac’s $15 Billion Takeover Bid as Family Backs Independence
Sika Raises 2026 Sales Outlook After Strong First-Half Results Beat Expectations
Galp Shares Fall After Q2 EBITDA Miss Despite Profit Beat and Higher Dividend
Philips Shares Slide 10% Despite Earnings Beat as Weak Orders Raise Growth Concerns
Seagate Stock Jumps as AI-Fueled Earnings Beat and Strong FY2027 Outlook Impress Investors
AstraZeneca Q2 Earnings Beat Forecasts as Oncology Growth Supports 2026 Outlook
BHP, Port Hedland Unions Fail to Reach Wage Deal as Negotiations Continue
Johnson & Johnson Proposes $5.5 Billion Talc Settlement to Resolve U.S. Ovarian Cancer Lawsuits 



